India looking to be self-reliant in development, production of vaccine against Covid-19

While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of Covishield vaccine developed by Oxford -Astra Zeneca. A total of 10 vaccine candidates have been supported by Department of Biotechnology so far at both academia and industry and as on date, five vaccine candidates are in the human trials stage.